Status:

ACTIVE_NOT_RECRUITING

Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin

Lead Sponsor:

ZIWIG

Collaborating Sponsors:

Monitoring Force Group

iGenSeq

Conditions:

Ovarian Cancer

Ovarian Cyst Benign

Eligibility:

FEMALE

18+ years

Brief Summary

OVAmiARN is a multicentre, prospective, longitudinal, non-interventional, observational study carried out in 8 obstetrics and gynecology departments in France; in order to describe the evolution of sa...

Eligibility Criteria

Inclusion Criteria:

  • Patient over 18 years of age,
  • A patient with an ovarian adnexal mass diagnosed by clinical examination and imaging and likely to be ovarian cancer, a borderline tumour or a benign cyst,
  • Patient with an indication for surgery
  • Patient has dated and signed the consent form,
  • Patient affiliated to the healthcare system,

Exclusion Criteria:

  • Pregnant patient
  • Patient infected with human immunodeficiency virus (HIV),
  • Patient with significant difficulties in reading or writing the French language.
  • Patient with another diagnosed cancer
  • Patient with a history of cancer less than 5 years old

Key Trial Info

Start Date :

May 4 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 1 2027

Estimated Enrollment :

746 Patients enrolled

Trial Details

Trial ID

NCT05514028

Start Date

May 4 2022

End Date

April 1 2027

Last Update

March 30 2026

Active Locations (21)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (21 locations)

1

CHU de Caen

Caen, Calvados, France, 14000

2

CGFL

Dijon, Côte d'Or, France, 21079

3

Institut Bergonié

Bordeaux, Gironde, France, 33076

4

CHU Strasbourg

Strasbourg, Haut-Rhin, France, 67200

Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin | DecenTrialz